| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/21/2002 | CN1364599A Nano blood tonifying medicine and its preparing method |
| 08/21/2002 | CN1364574A Nano medicine for supplementing qi and arresting bleeding and its preparing method |
| 08/21/2002 | CN1364567A Nano bleeding arresting medicine and its preparing method |
| 08/21/2002 | CN1364559A Nano astragalus root medicine and its preparing method |
| 08/21/2002 | CN1364556A Nano Liangge scan medicine and its preparing method |
| 08/21/2002 | CN1364542A Nano Xuening medicine and its preparing method |
| 08/21/2002 | CN1364516A Nano Breviscapine medicine and its preparing method |
| 08/21/2002 | CN1364514A Nano eight ingredient motherwort medicine and its preparing method |
| 08/21/2002 | CN1364513A Nano tranquilization medicine and its preparing method |
| 08/21/2002 | CN1364510A Nano seven ingredient beard beautifying medicine and its preparing method |
| 08/21/2002 | CN1364498A Nano three ingredient tribulus fruit medicine and its preparing method |
| 08/21/2002 | CN1364477A Nano weixuening medicine and its preparing method |
| 08/21/2002 | CN1364469A Method for preparing fres rehmannia root preparation |
| 08/21/2002 | CN1089247C Styptic and inflammation-relieving medicine and its preparing process |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437146 Mesangial proliferative glomerulonephritis |
| 08/20/2002 | US6437111 Bone morphogenetic protein-11 (BMP-11) compositions |
| 08/20/2002 | US6437000 Controlled release oral dosage for suitable for oral administration |
| 08/20/2002 | US6436985 Disubstituted pyrazolines and triazolines as factor Xa inhibitors |
| 08/20/2002 | US6436984 Melatonergic drugs that release nitrogen oxide and melatonin, used for prophylaxis of cardiovascular/nervous system, muscular disorders, antiischemic/inflammatory agents, reperfusion injuries, anemia and alzheimer's disease |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436901 Composition comprising hirudin, potassium phosphate and sugar, prepared by forming isotonic solution of hirudin, dipotassium hydrogen phosphate, and selected sugar at specified hirudin concentration and freeze drying solution |
| 08/20/2002 | US6436448 Treating lymphedema and for inducing weight-loss, guaifenesin |
| 08/20/2002 | US6436397 Reducing autodegradation during processing and purification. lyophilized solutioni with bulking agent, sucrose, trehalose, or raffinose |
| 08/20/2002 | CA2164321C Plasma-like solution |
| 08/20/2002 | CA2077695C Hydropyridine derivatives having antithrombotic activity |
| 08/20/2002 | CA2059124C Platelet aggregation inhibitors |
| 08/15/2002 | WO2002063025A2 Muscle-directed gene therapy with aav-1 and aav-6 vectors |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002062843A2 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | WO2002062792A1 Jnk inhibitor |
| 08/15/2002 | WO2002062778A2 Anti-thrombotic compounds, production and use thereof as medicaments |
| 08/15/2002 | WO2002062776A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors |
| 08/15/2002 | WO2002062775A1 2-acylaminothiazole derivative or its salt |
| 08/15/2002 | WO2002062748A1 Carboxylic amides, the production and use thereof as medicaments |
| 08/15/2002 | WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 08/15/2002 | WO2002062422A1 Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof |
| 08/15/2002 | WO2002062398A2 Radioactively labelled conjugates of phosphonates |
| 08/15/2002 | WO2002062377A2 Combined use of factor vii polypeptides and factor viii polypeptides |
| 08/15/2002 | WO2002062376A1 Combined use of factor vii polypeptides and factor ix polypeptides |
| 08/15/2002 | WO2002062335A2 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 08/15/2002 | WO2002062212A2 A personal condition management system |
| 08/15/2002 | WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses |
| 08/15/2002 | WO2002028433A3 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 08/15/2002 | WO2002026729A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/15/2002 | WO2002022212A8 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 08/15/2002 | WO2002022160A3 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 08/15/2002 | WO2002016381B1 Composition and method for inhibiting platelet aggregation |
| 08/15/2002 | US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/15/2002 | US20020111488 Beta-substitued beta-aminoethyl phosphonate derivatives |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111341 Bicyclic amino-pyrazinone compounds |
| 08/15/2002 | US20020111333 Hypotensive agents; cardiovascular disorders |
| 08/15/2002 | US20020111332 Alpha-substituted beta-aminoethyl phosphonate derivatives |
| 08/15/2002 | US20020111331 FGF-affinity chromatography |
| 08/15/2002 | US20020111315 Synergistic mixture with antilipemic agent |
| 08/15/2002 | US20020111296 Thrombomodulin analogs for use in recovery of spinal cord injury |
| 08/15/2002 | US20020111295 Agents for alleviating symptoms accompanied by inflammation |
| 08/15/2002 | US20020110914 Platelet suspensions and methods for resuspending platelets |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators |
| 08/15/2002 | US20020110552 Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme |
| 08/15/2002 | US20020110535 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437272A1 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | CA2437248A1 Jnk inhibitor |
| 08/15/2002 | CA2437015A1 Combined use of factor vii polypeptides and factor ix polypeptides |
| 08/15/2002 | CA2436837A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2436807A1 Combined use of factor vii polypeptides and factor viii polypeptides |
| 08/15/2002 | CA2435492A1 Antithrombotic compounds, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2434302A1 Therapeutic and diagnostic compounds, compositions, and methods |
| 08/15/2002 | CA2405524A1 A personal condition management system |
| 08/14/2002 | EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ |
| 08/14/2002 | EP1230394A1 Lentiviral vector transduction of hematopoietic stem cells |
| 08/14/2002 | EP1230369A2 Polypeptide hormone phosphatonin |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230263A1 A novel molecule |
| 08/14/2002 | EP1230259A1 S-allylmercaptoglutathione and uses thereof |
| 08/14/2002 | EP1230252A1 Beta-d-5-thioxylose derivatives, preparation method and therapeutic use |
| 08/14/2002 | EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 08/14/2002 | EP1230241A2 Adenosine receptor antagonists and methods of making and using the same |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 08/14/2002 | EP1229954A1 Method of treating cardio pulmonary diseases with no group compounds |
| 08/14/2002 | EP1189922A4 Steroid derivatives |
| 08/14/2002 | EP1096951B1 Use of bromelain proteases for inhibiting blood coagulation |
| 08/14/2002 | EP1087976B1 Polymorphic clopidogrel hydrogenesulphate form |
| 08/14/2002 | EP0977582B1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 08/14/2002 | EP0922054B1 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 08/14/2002 | EP0817614B1 Stable protein-phospholipid compositions and method of preparation |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | EP0665853B1 Multimeric polyvalent antithrombotic agents |
| 08/14/2002 | DE10105989A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 08/14/2002 | CN1364170A Thiophene A2A receptor agaonists |
| 08/14/2002 | CN1363346A Nano medicine 'Naoan' and its preparing process |
| 08/14/2002 | CN1363342A Nano medicine 'Mailuoning' and its preparing process |
| 08/14/2002 | CN1363338A Nano medicine 'Donggui Buxue' and its preparing process |